Biggest News Aggregation in the World
📰 Nasdaq Nlsp News

Nasdaq Nlsp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Nlsp. Real-time updates on events, politics, business and more.

Analyzing NLS Pharmaceutics (NASDAQ:NLSP) and GlycoMimetics (NASDAQ:GLYC)

NLS Pharmaceutics (NASDAQ:NLSP – Get Free Report) and GlycoMimetics (NASDAQ:GLYC – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Earnings and Valuation This table compares NLS Pharmaceutics and […]
United States National Cancer Institute Apollomics Hong Kong Glycomimetics Inc Get Free Report Given Glycomimetic

NLS Pharmaceutics (NASDAQ:NLSP) Trading 1.9% Higher

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) shares rose 1.9% during mid-day trading on Tuesday . The company traded as high as $1.11 and last traded at $1.07. Approximately 46,216 shares changed hands during trading, a decline of 27% from the average daily volume of 62,937 shares. The stock had previously closed at $1.05. NLS […]
Susquehanna International Group Renaissance Technologies Affinity Asset Advisors Pharmaceutics Company Profile Get Rating International Group

NLS Pharmaceutics (NASDAQ:NLSP) Stock Price Down 2.9%

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating)’s share price was down 2.9% during trading on Monday . The company traded as low as $1.23 and last traded at $1.34. Approximately 103,750 shares changed hands during trading, an increase of 48% from the average daily volume of 70,204 shares. The stock had previously closed at $1.38. […]
Pharmaceutics Company Profile Get Rating Nls Pharmaceutics Nasdaq Nlsp

NLS Pharmaceutics AG (NASDAQ:NLSP) Short Interest Update

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 126,700 shares, an increase of 44.3% from the March 15th total of 87,800 shares. Currently, 0.6% of the company’s stock are short sold. Based on an average […]
Get Rating Nls Pharmaceutics Nasdaq Nlsp
Source: wkrb13.com

NLS Pharmaceutics AG (NASDAQ:NLSP) Short Interest Update

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 134,500 shares, a growth of 40.8% from the May 15th total of 95,500 shares. Based on an average trading volume of 94,200 shares, the short-interest ratio is […]
Geode Capital Management Sigma Securities Citadel Advisors Get Rating Capital Management Sigma Advisers

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Zacks Investment Research Downgrades NLS Pharmaceutics (NASDAQ:NLSP) to Sell

NLS Pharmaceutics (NASDAQ:NLSP – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “NLS Pharmaceutics Ltd. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of therapies for rare and complex […]
Pharmaceutics Company Profile Get Rating Geode Capital Management Sigma Securities Zacks Investment Research Citadel Advisors Pharmaceutics Ltd

NLS Pharmaceutics AG (NASDAQ:NLSP) Short Interest Update

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 159,600 shares, a growth of 39.3% from the March 15th total of 114,600 shares. Based on an average daily volume of 282,700 shares, the short-interest ratio is […]
Pharmaceutics Company Profile Get Rating Geode Capital Management Sigma Securities Zacks Investment Research Citadel Advisors Get Rating

NLS Pharmaceutics (NASDAQ:NLSP) Upgraded to "Hold" at Zacks Investment Research

Zacks Investment Research upgraded shares of NLS Pharmaceutics (NASDAQ:NLSP – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, “NLS Pharmaceutics Ltd. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of therapies for rare and […]
Pharmaceutics Company Profile Get Rating Geode Capital Management Sigma Securities Zacks Investment Research Citadel Advisors Pharmaceutics Ltd

NLS Pharmaceutics AG (NASDAQ:NLSP) Short Interest Update

NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 143,100 shares, an increase of 246.5% from the February 13th total of 41,300 shares. Currently, 1.8% of the company’s stock are sold short. Based […]
Geode Capital Management Sigma Securities Zacks Investment Research Citadel Advisors Renaissance Technologies Get Rating

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science